Royal Bank of Canada »

Estrella Immunopharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Estrella Immunopharma (ESLA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Estrella Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Estrella Immunopharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Estrella Immunopharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0k 6.6k 1.06

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Estrella Immunopharma

Armistice Capital
Vanguard Group
Vanguard Capital Management
Wells Fargo & Company
Geode Capital Management
Vanguard Fiduciary Trust
Renaissance Technologies
State Street Corporation
BlackRock
Northern Trust
UBS Group
Royal Bank of Canada
Tower Research Capital
Toronto-Dominion Bank
Wolverine Asset Management

View all funds holding Estrella Immunopharma